Literature DB >> 7819880

Botulinum toxin in the cerebral palsies.

B Neville.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819880      PMCID: PMC2541774          DOI: 10.1136/bmj.309.6968.1526

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Botulinum toxin treatment of blepharospasm.

Authors:  J S Elston
Journal:  Adv Neurol       Date:  1988

2.  Double-blind study of botulinum toxin in spasmodic torticollis.

Authors:  J K Tsui; A Eisen; A J Stoessl; S Calne; D B Calne
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

3.  Cerebral palsy hip deformities: is there a consensus? II. Botulinum toxin A: a clinical experiment.

Authors:  E E Bleck
Journal:  J Pediatr Orthop       Date:  1994 May-Jun       Impact factor: 2.324

4.  Morphology of cerebral lesions in children with congenital hemiplegia. A study with computed tomography.

Authors:  L M Wiklund; P Uvebrant; O Flodmark
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Botulinum A chemodenervation: a new modality in cerebral palsied hands.

Authors:  S A Wall; L A Chait; J A Temlett; B Perkins; G Hillen; P Becker
Journal:  Br J Plast Surg       Date:  1993-12

6.  Botulinum toxin in the management of the lower limb in cerebral palsy.

Authors:  A P Cosgrove; I S Corry; H K Graham
Journal:  Dev Med Child Neurol       Date:  1994-05       Impact factor: 5.449

7.  Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse.

Authors:  A P Cosgrove; H K Graham
Journal:  Dev Med Child Neurol       Date:  1994-05       Impact factor: 5.449

8.  The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series.

Authors:  J F McLaughlin; K F Bjornson; S J Astley; R M Hays; S A Hoffinger; E A Armantrout; T S Roberts
Journal:  Dev Med Child Neurol       Date:  1994-09       Impact factor: 5.449

9.  Treatment of focal dystonias of the hand with botulinum toxin injections.

Authors:  L G Cohen; M Hallett; B D Geller; F Hochberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

10.  Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial.

Authors:  L A Koman; J F Mooney; B P Smith; A Goodman; T Mulvaney
Journal:  J Pediatr Orthop       Date:  1994 May-Jun       Impact factor: 2.324

  10 in total
  3 in total

1.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

2.  Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum Toxin and Cerebral Palsy Working Party.

Authors:  L J Carr; A P Cosgrove; P Gringras; B G Neville
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

3.  Proteomic changes in rat gastrocnemius muscle after botulinum toxin a injection.

Authors:  Nami Han; Hyun Dong Kim; Mi-Ja Eom; Jun Myeong You; Jin Han; Hyoung Kyu Kim; Mi Seon Kang
Journal:  Ann Rehabil Med       Date:  2013-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.